The role of hormones in renal disease and ischemia-reperfusion injury

Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 253

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-22-5_002

تاریخ نمایه سازی: 20 مهر 1398

Abstract:

The patients with renal diseases, especially end-stage renal disease (ESRD), are at high risk of developing cardiovascular disturbances. Some hormones such as brain natriuretic peptide appear to be important serum biomarkers in predicting cardiac death in ESRD patients. Renal diseases cause inflammation, anemia, uremic toxins, fluid overload, and electrolyte disturbance. Kidney transplantation is considered the choice treatment for patients with ESRD. Ischemia-reperfusion (IR), which occurs during renal transplantation is one of the factors that affect the outcome of renal transplantation. Renal graft rejection is the result of IR injury and there is no effective treatment to prevent IR injury. Reperfusion after ischemia may cause injury through generation of reactive oxygen and nitrogen species, inflammatory responses by increased levels of tumor necrosis factor-α (TNF-α) and interleukins (IL), and apoptotic processes, and leads to acute kidney injury (AKI). Thus, antioxidant, anti-apoptotic and anti-inflammatory hormones, which inhibit these pathways, can protect against IR injury and improve transplanted renal function in patients with ESRD.

Keywords:

Acute kidney injury Antioxidant , Hormones , Ischemia-reperfusion injury , Renal disease

Authors

Shokofeh Banaei

Social Determinants of Health (SDH) Research Center, Ardabil University of Medical Sciences, Ardabil, Iran|Department of Physiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran

Lotfollah Rezagholizadeh

Department of Biochemistry, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Xiao X, Tang R, Zhou X, Peng L, Yu P. ...
  • Gülçin I. Antioxidant activity of food constituents: an overview. Arch ...
  • Bursal E, Köksal E, Gülçin İ, Bilsel G, Gören AC. ...
  • Souza PC, Santos EBd, Motta GL, Bona SR, Schaefer PG, ...
  • Banaei S. Novel role of microRNAs in renal ischemia reperfusion ...
  • Cullingford TE, Wait R, Clerk A, Sugden PH. Effects of ...
  • Wang AY-M, Lam CW-K, Chan IH-S, Wang M, Lui S-F, ...
  • Aygen B, Dogukan A, Dursun F, Aydin S, Kilic N, ...
  • Koç M, Kumral ZNÖ, Özkan N, Memi G, Kaçar Ö, ...
  • Zhang W, Shu L. Upregulation of miR-21 by Ghrelin ameliorates ...
  • Lian M, Hewitson TD, Wigg B, Samuel CS, Chow F, ...
  • Volpe M. Natriuretic peptides and cardio-renal disease. Int J Cardiol ...
  • Möllsten A, Svensson M, Waernbaum I, Berhan Y, Schön S, ...
  • Herrera VL, Pasion KA, Moran AM, Ruiz-Opazo N. Worse renal ...
  • Patil CN, Wallace K, LaMarca BD, Moulana M, Lopez-Ruiz A, ...
  • Wetmore JB, Quarles LD. Calcimimetics or vitamin D analogs for ...
  • Gade K, Blaschke S, Rodenbeck A, Becker A, Anderson-Schmidt H, ...
  • Nitta K. Vascular calcification in patients with chronic kidney disease. ...
  • Omland T, Hagve T-A. Natriuretic peptides: physiologic and analytic considerations. ...
  • Spanaus K-S, Kronenberg F, Ritz E, Schlapbach R, Fliser D, ...
  • Gerbes AL, Vollmar AM, Kiemer AK, Bilzer M. The guanylate ...
  • Yasuda K, Kimura T, Sasaki K, Obi Y, Iio K, ...
  • Connell JM, Whitworth JA, Davies DL, Lever AF, Richards AM, ...
  • Raff H, Trivedi H. Circadian rhythm of salivary cortisol, plasma ...
  • Arregger AL, Cardoso EM, Tumilasci O, Contreras LN. Diagnostic value ...
  • Gulcin I, Buyukokuroglu ME, Oktay M, Kufrevioglu OI. On the ...
  • Gulcin İ, Buyukokuroglu ME, Kufrevioglu OI. Metal chelating and hydrogen ...
  • Beydemİr Sü, Gülçİn İ. Effects of melatonin on carbonic anhydrase ...
  • Ahmadiasl N, Banaei S, Alihemmati A. Combination antioxidant effect of ...
  • Lüdemann P, Zwernemann S, Lerchl A. Clearance of melatonin and ...
  • Wong HS-C, Chang C-M, Kao C-C, Hsu Y-W, Liu X, ...
  • Ahmadiasl N, Banaei S, Alihemati A, Baradaran B, Azimian E. ...
  • Georgatzakou HT, Tzounakas VL, Kriebardis AG, Velentzas AD, Papageorgiou EG, ...
  • Steinbrook R. Lower Erythropoietin Doses and Medicare Payment Reform: Win-Wins ...
  • Tong F, Tang X, Li X, Xia W, Liu D. ...
  • Idorn T, Knop FK, Jørgensen M, Holst JJ, Hornum M, ...
  • Emlet DR, Pastor-Soler N, Marciszyn A, Wen X, Gomez H, ...
  • Harada N, Zhao J, Kurihara H, Nakagata N, Okajima K. ...
  • نمایش کامل مراجع